Effects of the nitric oxide donor molsidomine on the early stages of liver damage in rats with bile duct ligation: A biochemical and immunohistochemical approach

European Surgical Research

Volumn 34, Issue 4, 2002, Pages 285-290

  Ozturk H ^a   Yagmur Y ^a   Buyukbayram, H ^a   Dokucu, A I ^a   Gurel, A ^b  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

Bile duct ligation; Hepatic fibrosis; Molsidomine; NG Nitro L arginine methyl ester; Nitric oxide

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; COLLAGEN TYPE 4; HYDROXYPROLINE; LIVER ENZYME; MOLSIDOMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER PARENCHYMA; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH TUBE;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHOLESTASIS; COLLAGEN; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GAMMA-GLUTAMYLTRANSFERASE; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; LIGATION; LIVER; LIVER CIRRHOSIS; MALE; MOLSIDOMINE; NECROSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE DONORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0036389483     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063069     Document Type: Article

References (27)

1. Marley R, Holt S, Fernando B, Harry D, Anand R, Goodier D, Davies S, Moore K: Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology 1999;29:1358-1363.
2. Singh S, Shackleton G, Ah-Sing E, Chakraborty J, Bailey ME: Antioxidant defenses in the bile duct-ligated rat. Gastroenterology 1992;103:1625-1629.
3. Parola M, Leonarduzzi G, Robino G, Albano E, Poli G, Dianzani MU: On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic Biol Med 1996;20:351-359.
4. Britton RS, Bacon BR: Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 1994;41:343-348.
5. Harbrecht B, Billiar TR, Stadler J, Demetris AJ, Ochoa JB, Curran RD, Simmons RL: Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992;20:1568-1574.
6. Nishida J, McCuskey RS, McDonnell D, Fox ES: Protective role of NO dysfunction during endotoxemia. Am J Physiol 1994;267:G1135-G1141.
7. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 1990;48:565-569.
8. Duval DL, Sieg DJ, Billings RE: Regulation of hepatic nitric oxide synthase by reactive oxygen intermediates and glutathione. Arch Biochem Biophys 1995;316:699-706.
9. Darley-Usmar V, Wiseman H, Halliwell B: Nitric oxide and oxygen radicals: A question of balance. FEBS Lett 1995;369:131-135.
10. Shiomi M, Wakabayashi Y, Sano Tsuyoshi T, Shinoda Y, Nimura Y, Yuzuru I, Suematsu M: Nitric oxide suppression reversibly attenuates mitochondrial dysfunction and cholestasis in endotoxemic rat liver. Hepatology 1998;27:108-115.
11. Kukovetz WR, Holzmann S: Cyclic GMP as the mediator of molsidomine-induced vasodilatation. Eur J Pharmacol 1986;122:130-109.
12. Walder CE, Thiemermann C, Vane JR: The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 1991;102:967-973.
13. Criado M, Flores O, Ortíz MC, Hidalgo F, Rodriguez-Lopez AM, Eleno N, Atucha NM, Sanchez-Rodriguez A, Arevalo M, Garcia-Estan J, Lopez-Novoa JM: Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: Role of inducible nitric oxide synthase activation. Hepatology 1997;262:268-276.
14. Spackman DH, Stein WH, Moore S: Automatic recording apparatus for use in the chromatography of amino acids. Anal Chem 1958;30:1190-1206.
15. Tuchweber B, Desmoulière A, Bochaton-Piallat ML, Rubbia-Brandt L, Gabbiani G: Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest 1996;74:265-278.
16. Desmoulière A, Darby I, Costa AM, Raccurt M, Tuchweber B, Sommer P, Gabbiani G: Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat. Lab Invest 1997;76:765-778.
17. Ignarro LJ, Bugy GM, Wood KS, Byrns RE, Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9269.
18. Stuehr DJ, Marletta MA: Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-gamma. J Immunol 1987;139:518-525.
19. Stadler J, Bergonia HA, Di Silvio M, Sweetland MA, Billiar TR, Simmons RL, Lancaster JR Jr: Nonheme iron-nitrosyl complex formation in rat hepatocytes: Detection by electron paramagnetic resonance spectroscopy. Arch Biochem Biophys 1993;302:4-11.
20. Adamson GM, Billings RE: Cytokine toxicity and induction of NO synthase activity in cultured mouse hepatocytes. Toxicol Appl Pharmacol 1993;119:100-107.
21. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR: Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993;90:3491-3495.
22. Laskin DL, Heck DE, Feder LS, Gardner CR, Laskin JD: Regulation of nitric oxide production by hepatic macrophages and endothelial cells; in Knook DL, Wisse E (eds): Cells of the Hepatic Sinusoid. Leiden, Kupffer Cell Foundation. 1993, pp 26-28.
23. Geller DA, Nussler AK, Di Silvio M, Lowenstein CJ, Shapiro RA, Wang SC, Simmons RL, Billiar TR: Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993;90:522-526.
24. Pfeilschifter J, Kunz D, Mühl H: Nitric oxide: An inflammatory mediator of glomerular mesangial cells. Nephron 1993;64:518-525.
25. Kukovetz WR, Holzmann S: Mechanism of vasodilation by molsidomine. Am Heart J 1985;109:637-640.
26. Pei Q, Wang D, Jiang M: Dynamic changes of nitric oxide and biochemistry in rats with intrahepatic cholestasis. Chung Hua Kan Tsang Ping Tsa Chih 1999;7:44-45.
27. Mayoral P, Criado M, Hidalgo F, Flores O, Arevalo MA, Eleno N, Sanchez-Rodriguez A, Lopez-Novoa JM, Esteller A: Effects of chronic nitric oxide activation or inhibition on early hepatic fibrosis in rats with bile duct ligation Clin Sci 1999;96,297-305.